9 results
8-K
EX-99.2
APGE
Apogee Therapeutics, Inc.
12 Aug 24
Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2024 Financial Results
6:35am
Designed to maximize antibody recycling Drug exists at higher levels for longer effect Potency Viscosity PK Stability Backbone Based on clinically
8-K
EX-99.1
APGE
Apogee Therapeutics, Inc.
5 Mar 24
Regulation FD Disclosure
8:15am
recycling Drug exists at higher levels for longer effect Potency Viscosity PK Stability Backbone Based on clinically-validated epitopes
10-K
2023 FY
APGE
Apogee Therapeutics, Inc.
5 Mar 24
Annual report
6:15am
by supercharging the body’s innate recycling mechanism for antibodies. Antibodies in circulation are naturally taken up by cells and degraded, which limits … their half-life. This recycling mechanism works via the neonatal Fc receptor (FcRn). Antibodies are internalized into a cell via pinocytosis
DRS
APGE
Apogee Therapeutics, Inc.
9 Feb 24
Draft registration statement
12:00am
by supercharging the body’s innate recycling mechanism for antibodies. Antibodies in circulation are naturally taken up by cells and degraded, which … extending their half-life. This recycling mechanism works via the neonatal Fc receptor (FcRn). Antibodies are internalized into a cell via pinocytosis
424B4
APGE
Apogee Therapeutics, Inc.
17 Jul 23
Prospectus supplement with pricing info
4:08pm
the body’s innate recycling mechanism for antibodies. Antibodies in circulation are naturally taken up by cells and degraded, which limits the half-life … . This recycling mechanism works via the neonatal Fc receptor (FcRn). Antibodies are internalized into a cell via pinocytosis, the process
S-1
vwzgqufb ghnpbljo
22 Jun 23
IPO registration
4:19pm
DRS/A
9cqen18y3ll2
5 Jun 23
Draft registration statement (amended)
12:00am
DRS
guiio gt6492
28 Apr 23
Draft registration statement
12:00am
- Prev
- 1
- Next